Evaluation of water gargle samples for SARS-CoV-2 detection using Abbott ID NOW COVID-19 assay
- PMID: 35535382
- PMCID: PMC9348367
- DOI: 10.1002/jmv.27847
Evaluation of water gargle samples for SARS-CoV-2 detection using Abbott ID NOW COVID-19 assay
Abstract
The Abbott ID NOW™ COVID-19 assay has been shown as a reliable and sensitive alternative to reverse transcription-polymerase chain reaction (RT-PCR) testing from nasopharyngeal or nasal samples in symptomatic patients. Water gargle is an acceptable noninvasive alternative specimen for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) detection by RT-PCR. The objective of this study was to evaluate the performance of water gargle samples for the detection of SARS-CoV-2 using the ID NOW. Residual gargle samples were randomly selected among positive standard of care (SOC)-nucleic acid amplification test (NAAT) samples. For testing on ID NOW, the manufacturer's instructions were followed, except for the specimen addition step: 500 µl of the gargle specimen was added to the blue sample receiver with a pipette and gently mixed. Among the 202 positive samples by SOC-NAAT, 185 were positive by ID NOW (positive percent agreement [PPA]) = 91.6% (95% confidence interval [CI]: 86.9-95.0). For the 17 discordant samples, cycle threshold (Ct ) values were all ≥31.0. The PPA was significantly lower among asymptomatic patients (84.4%; 95% CI: 73.2-92.3) versus symptomatic patients (95.2%; 95% CI: 89.8-98.2). The performance of the ID NOW for the detection of SARS-CoV-2 infection on gargle samples is excellent when Ct values are <31.0 and for patients that have COVID-19 compatible symptoms.
Keywords: Abbott ID NOW; COVID-19; SARS-CoV-2; gargle.
© 2022 Wiley Periodicals LLC.
Similar articles
-
Analytical performance of the Abbott ID NOW 2.0 assay for SARS-CoV-2 detection in clinical samples from symptomatic patients.Diagn Microbiol Infect Dis. 2024 Mar;108(3):116164. doi: 10.1016/j.diagmicrobio.2023.116164. Epub 2023 Dec 21. Diagn Microbiol Infect Dis. 2024. PMID: 38157639
-
Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.J Clin Microbiol. 2020 Jul 23;58(8):e01136-20. doi: 10.1128/JCM.01136-20. Print 2020 Jul 23. J Clin Microbiol. 2020. PMID: 32471894 Free PMC article.
-
Abbott ID NOW™ COVID-19 assay: do not discard the swab.Diagn Microbiol Infect Dis. 2023 Apr;105(4):115832. doi: 10.1016/j.diagmicrobio.2022.115832. Epub 2022 Oct 13. Diagn Microbiol Infect Dis. 2023. PMID: 36731196 Free PMC article.
-
Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.J Med Virol. 2021 Jul;93(7):4523-4531. doi: 10.1002/jmv.26994. Epub 2021 May 3. J Med Virol. 2021. PMID: 33913533 Free PMC article.
-
Sensitivity of ID NOW and RT-PCR for detection of SARS-CoV-2 in an ambulatory population.Elife. 2021 Apr 20;10:e65726. doi: 10.7554/eLife.65726. Elife. 2021. PMID: 33876726 Free PMC article.
Cited by
-
Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer.Microbiol Spectr. 2022 Aug 31;10(4):e0063922. doi: 10.1128/spectrum.00639-22. Epub 2022 Jul 13. Microbiol Spectr. 2022. PMID: 35863036 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous